Vyant Bio Announces Stockholder Approval of Proposed Asset Sale; 64,110 Votes Needed to Approve Plan of Dissolution; and Adjournment of Special Meeting of Stockholders
Stock Information for Interpace Biosciences Inc.
Loading
Please wait while we load your information from QuoteMedia.